AMG National Trust Bank Takes Position in Danaher Corporation $DHR

Key Points

• AMG National Trust Bank acquired 18,067 Danaher shares during the second quarter, valued at approximately $3.44 million. Other institutional investors also initiated positions, with institutions collectively owning 79.05% of DHR shares.
• Analysts maintain a generally positive view, with Danaher carrying a consensus “Moderate Buy” rating and a $228.91 price target. Recent targets range from $200 to $250, including buy, overweight, neutral and hold ratings.
• Danaher exceeded quarterly expectations, reporting $1.94 in earnings per share versus the $1.85 consensus and $6.26 billion in revenue, up 5.5% year over year. The stock recently opened at $202.51.

AMG National Trust Bank acquired a new position in Danaher Corporation (NYSE:DHR - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 18,067 shares of the conglomerate's stock, valued at approximately $3,441,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in DHR. Roman Butler Fullerton & Co. acquired a new stake in Danaher during the 2nd quarter valued at $294,000. Simplicity Wealth LLC acquired a new position in Danaher during the second quarter valued at $214,000. Wealth Effects LLC purchased a new stake in Danaher in the 2nd quarter worth about $439,000. Trivium Point Advisory LLC purchased a new stake in Danaher in the 2nd quarter worth about $334,000. Finally, Chase Investment Counsel Corp acquired a new stake in Danaher during the 2nd quarter worth about $240,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Piper Sandler initiated coverage on Danaher in a report on Thursday, June 11th. They issued a "neutral" rating and a $200.00 target price on the stock. JPMorgan Chase & Co. decreased their price target on shares of Danaher from $275.00 to $245.00 and set an "overweight" rating for the company in a report on Wednesday, April 22nd. Citigroup assumed coverage on shares of Danaher in a research note on Tuesday, May 26th. They issued a "buy" rating and a $230.00 price objective on the stock. Wall Street Zen downgraded shares of Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, April 25th. Finally, UBS Group decreased their target price on shares of Danaher from $270.00 to $250.00 and set a "buy" rating for the company in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Danaher currently has a consensus rating of "Moderate Buy" and a consensus price target of $228.91.

Danaher Stock Performance

DHR stock opened at $202.51 on Monday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $142.37 billion, a price-to-earnings ratio of 35.97, a P/E/G ratio of 2.52 and a beta of 0.78. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm has a 50 day moving average of $193.14 and a two-hundred day moving average of $192.91.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts' consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter last year, the firm earned $0.77 EPS. Danaher's revenue for the quarter was up 5.5% on a year-over-year basis. As a group, equities analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source